Infection Control Today® Editorial Staff

In terms of severe post-acute complications from COVID-19, there is a low relative risk for those who were not admitted to the hospital.

CDC data show that mRNA COVID-19 vaccines reduced the risk of getting sick with COVID-19 by 94% among health care personnel who were fully vaccinated.

The risk of COVID-19 surface transmission is low, says the CDC, and is especially low outdoors.

Though tough months lie ahead for infection preventionists and other healthcare professionals, hope remains that at some point in 2021 things will begin to settle down. In the end, it comes down to a simple formula: We win, COVID-19 loses.

A panel of experts advising the FDA voted 20-1 (with 1 abstention) to tell the FDA that it should grant an emergency use authorization to Moderna's COVID-19 vaccine.

Bamlanivimab, a monoclonal antibody, can be used for anyone 65 or older. It can also be used for patients 12 and over who have an underlying health condition and have been diagnosed with mild-to-moderate COVID-19.

The MJH Life Sciences COVID-19 Coalition experts share their insights on the state of the pandemic.